Oxford scientists map the cells that drive Crohn’s disease fistulas
12 November 2025
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.
Oxford joins £15.9m national initiative to transform cancer research using live human tissue models
11 November 2025
Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise the use of live human tumour samples to enhance the accuracy of preclinical research, speed up drug discovery, and reduce dependence on animal testing.
Shame a significant factor in hairpulling in young people, new study finds
10 November 2025
It found that shame partially explained the relationship between hairpulling and depression, and fully explained the relationship between hairpulling and anxiety.
From pain to policy: global reviews call for urgent action on endometriosis in most world regions
5 November 2025
First global mapping shows half the world’s countries lack policies or guidelines for endometriosis, affecting >200 million women and girls.
Oxford scientists capture genome’s structure in unprecedented detail
5 November 2025
Radcliff Department of Medicine scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
New Microbiome Innovation Network to drive UK Bioscience Research
5 November 2025
Researchers from the Kennedy Institute are part of a UK-wide consortium that has been awarded a £644K BBSRC Network Grant to establish the Microbiome Innovation Network (Microbiome-Net).
New study to investigate link between gut microbiome and emotional and cognitive wellbeing in early menopause
5 November 2025
The research will add to a growing body of evidence on the effects of probiotics on mood and cognition and their ability to positively affect menopausal symptoms.
Symposium honours the life and legacy of Professor Tipu Aziz
5 November 2025
The Nuffield Department of Surgical Sciences (NDS) hosted a special symposium on Friday 17 October 2025 in honour of Professor Tipu Aziz (1956–2024), Emeritus Professor of Neurosurgery and founder and head of Oxford Functional Neurosurgery.
New research published: How the brain conquers the third dimension
4 November 2025
Members of the Department of Physiology, Anatomy and Genetics (DPAG) are part of an international collaborative team that has published new research in Proceedings of the National Academy of Sciences.
The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences enhances surgical research capacity in Vietnam
3 November 2025
Prof David Beard was the keynote speaker at a recent Surgical Trials Workshop in Ho Chi Minh City, Vietnam, contributing to improved treatment quality and greater international integration in healthcare and medical science.
New AI tool could improve prostate cancer treatment
3 November 2025
A ground-breaking new study will test how artificial intelligence (AI) can make prostate cancer diagnosis more accurate. The study by the University of Oxford is funded by a £1.9m grant from research charity Prostate Cancer UK.
Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn
31 October 2025
OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition was announced in August 2025.
Key blood test for identifying people with heart failure less accurate in those with atrial fibrillation, new study finds
30 October 2025
A large new study led by researchers in the Nuffield Department of Primary Care Health Sciences has found that a common blood test used to help diagnose heart failure is less accurate in people who also have atrial fibrillation (AF).
The GEKO trial launches to bridge the gap in knee osteoarthritis care
30 October 2025
A new multicentre trial to evaluate a minimally invasive treatment for patients with knee osteoarthritis could transform the way knee osteoarthritis is managed, potentially improving quality of life for patients long before surgery becomes necessary.
Oxford-led study shows vaccine protection against Paratyphoid
30 October 2025
Results from a study published in The New England Journal of Medicine show that a vaccine can protect people against Salmonella Paratyphi A infection.
Oxford strengthens strategic partnerships with Vietnam in health, education and climate innovation
30 October 2025
The University of Oxford has signed three landmark agreements with leading Vietnamese partners, deepening collaboration across healthcare, higher education and sustainable aviation.
The Nuffield Department of Surgical Sciences celebrates two Cancer Research UK awards for colorectal cancer research
29 October 2025
NDS is celebrating the achievements of Professor Simon Buczacki and Dr Alex Gordon-Weeks, who have both received CRUK Discovery Programme Awards — a rare double success for a single university department.
Soft drinks tax changes 'miss opportunity' to tackle highest-sugar products
28 October 2025
Nuffield Department of Primary Care Health Science's researchers find government's soft drinks tax changes miss opportunity to maximise health benefits. Analysis shows targeting highest-sugar products could remove twice as much sugar from market as current proposals, particularly benefiting deprived areas.
Study finds no significant differences in growth between children exposed to HIV in the womb and those unexposed
28 October 2025
A new study led by researchers at Oxford Population Health has found no significant differences in growth up to two years of age between children who were exposed to HIV during pregnancy but remained uninfected and those born to mothers without HIV. The study is published in eClinicalMedicine.
Oxford Oncology at ESMO 2025
27 October 2025
Members of the Department of Oncology attended ESMO earlier this month to present their research, chair sessions, and network with collaborators from across Europe and beyond. Read the highlights from our department’s contributions to ESMO 2025.